HIGHLIGHTS
- who: Mengying Jiang and collaborators from the Center for Uterine Cancer Diagnosis and Therapy Research of Zhejiang Province, Department of Obstetrics and, Affiliated Hospital of Wenzhou Medical University, Wenzhou, China have published the research: DHODH Inhibition Exerts Synergistic Therapeutic Effect with Cisplatin to Induce Ferroptosis in Cervical Cancer through Regulating mTOR Pathway, in the Journal: Cancers 2023, 15, 546. of /2023/
- what: This study proposed that the combination of DHODH inhibition and cisplatin offers a potential treatment for cervical cancer. The study proposes the possibility to use brequinar combined with cisplatin for treating recurrent and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.